AU Patent

AU2008282743B2 — Sublingual fentanyl spray

Assigned to Insys Therapeutics Inc · Expires 2012-11-29 · 13y expired

What this patent protects

The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable salt thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.

USPTO Abstract

The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable salt thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.

Drugs covered by this patent

Patent Metadata

Patent number
AU2008282743B2
Jurisdiction
AU
Classification
Expires
2012-11-29
Drug substance claim
No
Drug product claim
No
Assignee
Insys Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.